LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Similar documents
The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

! slow, progressive, permanent loss of neurologic function.

FTD basics! Etienne de Villers-Sidani, MD!

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Form D1: Clinician Diagnosis

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Biomarkers: Translating Research into Clinical Practice

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

I do not have any disclosures

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Clinical Genetics & Dementia

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Sandra Weintraub, PhD Clinical Core Leader and Professor

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Phenotypic Variability in ALS

Frontotemporal dementia:

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

The genetics and neuropathology of frontotemporal lobar degeneration

Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration

Presenter Disclosure Information. I have no financial relationships to disclose:

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Prof Tim Anderson. Neurologist University of Otago Christchurch

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

What is. frontotemporal. address? dementia?

Form A3: Subject Family History

Paper Title Theme Presentation Type Poster Presentatio n Day

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

2016 Programs & Information

Frontotemporal Degeneration

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA

Supplementary Online Content

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

Confronting the Clinical Challenges of Frontotemporal Dementia

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC

What is frontotemporal dementia?

Dementia Past, Present and Future

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON

Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease

FTD: Improving Outcomes & Outreach

ALS and Frontotemporal Dementia. Catherine Lomen-Hoerth, MD, PhD Professor of Neurology University of California, San Francisco

Dr Fiona Kumfor University of Sydney

What is frontotemporal dementia (FTD)?

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC

Selective Vulnerability of von Economo Neurons in Frontotemporal Dementia

FTD/PPA Caregiver Education Conference March 11, 2011

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

C9orf72 promoter hypermethylation is neuroprotective Neuroimaging and neuropathologic evidence

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY

Narrative discourse deficits in amyotrophic lateral sclerosis

Frontotemporal Dementia

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

Overview of the non-alzheimer Dementias

doi: /brain/awr198 Brain 2011: 134;

Clinical phenotypes in autopsy-confirmed Pick disease

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

The ABCs of Dementia Diagnosis

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

Dementia and Aphasia-AD, FTD & aphasia

Frontotemporal Degeneration

Non Alzheimer Dementias

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications.

Outline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks

Impaired action knowledge in amyotrophic lateral sclerosis

Early Onset Dementia From the background to the foreground

Frontal Behavioural Inventory (FBI)

Epidemiology of dementia. TA Treves, MD

Moving Targets: An Update on Diagnosing Dementia in the Clinic

What is primary progressive aphasia?

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

Psy /16 Human Communication. By Joseline

European Prevention of Alzheimer s Dementia (EPAD)

What s New in Dementia?

doi: /brain/awt165 Brain 2013: 136; Comparative semantic profiles in semantic dementia and Alzheimer s disease

Introduction to Physiological Psychology Review

FDG-PET e parkinsonismi

Cognitive Ability (Decline) & Social Isolation

Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer s disease

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

A Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd):

Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

review of existing studies on ASL in dementia Marion Smits, MD PhD

Transcription:

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the Wyncote Foundation Consultant for TauRx and Forum Pharmaceuticals No conflict of interest to declare

LANGUAGE IN FRONTOTEMPORAL DEGENERATION Language is a uniquely human process Single words are used to construct sentences Sentences are used in conversations Inexpensive screening device with potentially high sensitivity and specificity for FTD spectrum pathology Disease-modifying treatment trials

LANGUAGE IN FRONTOTEMPORAL DEGENERATION Plan of talk Disorders of language in aphasic and non-non-aphasic variants of FTD Semantic variant PPA Non-fluent/agrammatic PPA Behavioral variant FTD Impairments in FTD selectively compromise each level of language Markers for specific FTD pathology

FRONTOTEMPORAL DEGENERATION Two major phenotypes Primary progressive aphasia Semantic variant PPA (Semantic dementia) Nonfluent/agrammatic PPA (Progressive non-fluent aphasia) Behavioral variant frontotemporal degeneration SD PNFA bvftd

SEMANTIC VARIANT PPA Lexical semantic and object knowledge is compromised in

VISUAL FEATURE KNOWLEDGE IN SEMANTIC VARIANT PPA Degraded object concepts in svppa Difficulty with naming and comprehension Less impaired abstract concepts % rect Degraded visual features of objects Disease in visual association cortex co r 50 0.00 HAND -0.85-1.70 G LOVE SHOE -2.55-3.40 z-score Two-alternative forced-choice 90 70 ABSTRACT CONCRETE CONTROL svppa Bonner et al, 2009

NUMBER CONCEPTS IN svppa Despite profound word comprehension and object knowledge deficits, svppa patients are rapid and accurate at performing written number calculations

MUSIC IN svppa Weinstein et al, 2011 Preserved music knowledge in svppa

PATHOLOGY IN SEMANTIC VARIANT PPA Autopsy shows anterior temporal atrophy Neuronal dropout in superficial layers TDP-43 neuronal inclusions Found in about 85% of cases

SPECTRUM OF CLINICAL DISEASE IN TDP-43 PATHOLOGY TDP-43 pathology in both FTLD and ALS ALS ALS FTLD FTLD FTLD-ALS link confirmed by TARDBP mutation and C9orf72 expansion

McCluskey et al, 2014 SPECTRUM OF CLINICAL DISEASE IN TDP-43 PATHOLOGY ALS-classic Pyramidal/neuromuscular disease ALS is a multi-system disorder 10% with ALS-FTD 34% with ALS-MCI 15% with ALS-Plus ALS with cerebellar, extrapyramidal, oculomotor, 40 or autonomic features Significantly poorer prognosis, 20 marker for inherited disease 0 months survival ALS-classic ALS-Plus

SEMANTIC VARIANT PPA Semantic variant PPA Degraded representations of single word and object concepts Preserved number and music concepts Related to anterior and ventral temporal disease Clinical marker for TDP-43 pathology Pathology shared with ALS

NON-FLUENT/AGRAMMATIC PPA Speech fluency and grammatical comprehension are impaired in progressive

NON-FLUENT/AGRAMMATIC PPA Significantly slowed speech Significant grammatical deficit - Expression deficit Significantly simplified grammar in utterances - Comprehension deficit Significantly impaired grammatical comprehension Impaired oral and written langu 100 ect r 90 cor 80 % 70 frontal and superior temporal atrophy Gunawardena Dual white et al, 2010 matter routes % complex structures nap PA nappa 150 40 svppa bvftd Control 30 20 50 10 words/minute # age 0 100 Ash et al, 2010 control Grossman et al, cleft 2014 center Grammatical deficit related to left inferior * * * Charles et al, 2014 svppa

NON-FLUENT/AGRAMMATIC PPA nappa deficit is selective nappa are good at naming and complex figure construction z-score 0.0-1.0-2.0-3.0-4.0-5.0 Boston Naming Rey Figure Copy nappa svppa bvftd CBD Libon et al, 2010

NON-FLUENT/AGRAMMATIC PPA Gross pathology in non-fluent/agrammatic PPA

NON-FLUENT/AGRAMMATIC PPA Pick bodies balloon cells Courtesy John Q. Trojanowski MD, PhD Microscopic pathology in non-fluent/agrammatic PPA H & E preparation Tau-immunoreactive histopathology Misfolded tau due to hyperphosphorylation Disturbs microtubule structure Tau found in about 75% of cases

SPECTRUM OF CLINICAL DISEASE IN TAU PATHOLOGY Ta u pathology in both nappa and PSP/ FTLD% PSP/CBD%

SPECTRUM OF CLINICAL DISEASE IN TAU PATHOLOGY Anatomic distribution of tau pathology in PSP and CBD PSP CBD Irwin et al, 2012

NON-FLUENT/AGRAMMATIC PPA Non-fluent/agrammatic PPA Specific pattern of impaired language due to limited grammatical processing Associated with left inferior frontal disease Similar pathology in akinetic-rigid disorders such as CBD and PSP Clinical screen for tau pathology

BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Poor self-regulation, impulsive, disinhibited Rigid, obsessive, rituals Apathetic Lack of insight Poor empathy

BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Frontal and anterior temporal gray matter Extensive white matter disease

BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Impaired social judgment in bvftd b vftd impaired Correlation with comp of social judgments cartoon prediction flexibility ToM 2nd order onents empathy 0.87 0.72 0.37 Eslinger et al, 2007

SEMISTRUCTURED SPEECH SAMPLE Wordless picture story, 30 events, 7 episodes Single word expression Sentence expression Narrative organization

BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Accurate description of content of children s wordless p icture story Poor organization of % global connectedness narrative No sense of the p oint of the story 100 75 50 25 0 bvftd nappa svppa c ontrol Impaired global connectedness Impaired local connectedness Impaired theme maintenance Ash et al, 2006 Reduced connectedness related to prefrontal atrophy

BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Atrophy in behavioral variant frontotemporal degeneration 50% TDP-43 pathology, 50% tau pathology

DIAGNOSIS IN FRONTOTEMPORAL DEGENERATION Multimodal strategy for diagnosis CLINICAL MRI MOLECULAR GENETIC CSF

FAMILIAL FRONTOTEMPORAL DEGENERATION FTLD autosomal dominant inheritance in 25.1% Mutation identified in 20.1% of patients Chromosome 17 MAPT Chromosome 17 GRN Chromosome 9 C9orf72 Chromosome 9 VCP Chromosome 3 CHMP2B Chromosome 1 TARDBP Specific pathology associated with each mutation

IMAGING BIOMARKERS FOR YOUNG ONSET FTD Eigenanatomy imaging distinguishes FTLD-tau from FTLD-TDP with known pathology tau TDP WM myelin WM inclusions GM neuronal dropout GM inclusions McMillan et al, 2013

BIOFLUID BIOMARKERS FOR FTLD CSF phosphorylated tau abnormal in tauopathy Elevated CSF ptau:ttau in tauopathy Lower ptau:ttau in TDP-43 proteinopathy Related to motor and PFC in ALS Grossman et al, 2014 Related to midbrain in PSP

McMillan et al, 2014 MOLECULAR BIOMARKERS IN HUMAN TAUOPATHY Myelin oligodendrocyte basic protein Stabilizes myelin rs1768208 (MOBP) is associated with reduced white matter fractional anisotropy in midbrain and superior longitudinal fasciculus Locus of white matter pathology in progressive pathology

MOLECULAR BIOMARKERS IN HUMAN TAUOPATHY Minor T allele at rs1768208 of MOBP associated with reduced survival in clinical FTD and known tauopathy clinical FTD known tau pathology Irwin et al, 2014 Validated by imaging-guided biopsy of SLF showing diseased myelin in risk allele carriers (right) Minor T allele at rs1768208 of MOBP associated with reduced FA in white matter of superior longitudinal fasciculus and brain stem

LANGUAGE IN FRONTOTEMPORAL DEGENERATION Language is a complex process that can serve as a sensitive and inexpensive screen for FTD Single words and object knowledge compromised in semantic variant PPA Marker of TDP-43 pathology Grammatical expression and comprehension impaired in non-fluent/ agrammatic PPA Marker of tau pathology Narrative conversation difficulty in